HLA class I and II and TNF-α gene polymorphisms in sarcoidosis patients;Estudo de polimorfismos genéticos do HLA (classes I e II) e do TNF-α em doentes com sarcoidose

Revista Portuguesa de Pneumologia

Volumn 14, Issue 6, 2008, Pages 727-746

  Morais, António ^a   Alves, Helena ^b   Lima, Bruno ^b   Delgado, Luís ^c   Gonçalves, Ricardo I ^b   Tafulo, Sandra ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Histocompatability Centre of the North   (Portugal)

^c Porto Faculty of Medicine   (Portugal)

Author keywords

Genetics; HLA; Sarcoidosis

Indexed keywords

DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA EXTRACTION; ERYTHEMA NODOSUM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYBRIDIZATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; RADIODIAGNOSIS; SARCOIDOSIS;

EID: 60849108667     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30284-1     Document Type: Article

References (42)

1. Hunninghake GW, Costabel U, Ando M. ATS/ERS/WASOG Statement on Sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-55.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65.
3. Baughman RP, Lower EE, du Bois R. Sarcoidosis. Lancet 2003; 361: 1111.
4. Iannuzzi MC, Rybicki BA. Genetics ofn sarcoidosis; candidate genes and genome scans. Proc Am Thorac Soc 2007; (4):108-16.
5. Rybicki BA, Iannuzzi MC, Frederick MM et al. Familial aggregation of sarcoidosis. A case control etiologic study of sarcoidosis (ACCESS). Am J Repir Crit Care Med 2001; 164: 2085.
6. Klein J, Sato A. The HLA System. N Engl J Med, 2000; 343, 10: 702-709
7. Rybicki BA, Iannuzzi MC. Sarcoidosis and human leucocyte antigen class I and II genes. Am J Respir Crit Care Med 2004; 169: 665-666.
8. Brewerton D, Cockburn C, James D, et al. HLA antigens in sarcoidosis. Clin Exp Immunol 1977; 27: 227-229.
9. Olenchock S, Heise E, Marz J, et al. HLA-B8 in sarcoidosis. Ann Allergy 1981; 47: 151-153.
10. Lenhart K, Kolek V, Bartova A. HLA antigens associated with sarcoidosis. Dis Markers 1990; 8: 23-29.
11. Dubaniewicz A, Szczerkowska Z. HLA-A,B,C antigens in pulmonary sarcoidosis in Polish population. Arch Immunol Ther Exp (Warz) 1999; 47 (1): 55-9.
12. Pasturenzi L, Martinetti M, Cuccia M. HLA class I, II, III polymorphism in Italian patients with sarcoidosis. Chest 1993 Oct; 104 (4): 1170-5.
13. Martinetti M, Tinelli C, Kolek V, et al. 'The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152:557-64.
14. Sharma S, Balamurugan A, Pandey R, et al. Human leukocyte antigen - DR alleles influence the clinical course of pulmonary sarcoidosis in asian Indians. Am J Respir Cell Mol Biol 2003; 29: 225-31.
15. Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin Proc 2003; 78(4):436-42.
16. McIntyre J, Mckee K, Loadholt C, et al. Increased HLA - B7 antigen frequency in South Caroline blacks in association with sarcoidosis. Transplant Proc 1977; 9: 173-176.
17. Rutherford RM, Brutshe MH, Kearns M, et al. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21(3):191-8.
18. Smith M, Turton C, Mitchell D, et al. Association of HLA-B8 with spontaneous resolution in sarcoidosis. Thorax 1981; 36: 296-298.
19. Grunewald J, Eklund A, Olerup O. Human luekocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696-702.
20. Ishihara M, Inoko H, Suzuki K, et al. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR - RFLP. Jpn J Ophthalmol 1996; 40: 540-3.
21. Ishihara M, Ishida T, Inoko H, et al. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn J Ophthalmol 1996; 40: 86-94.
22. Nowack D, Goebel KM. Genetic aspects of sarcoidosis. ClassII histocompatibility antigens and a family study. Arch Intern Med 1987; 147: 481-3.
23. Rossman MD, Thomson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720-35.
24. Iannuzzi M, Maliarik M, Poisson L, et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003; 1670:1225-31.
25. Grutters J, Sato H, Welsh K, et al. Am J Respir Cell Mol Biol 2003; 29:S59-S62.
26. Voorter CE, Drent M, Van den Berger-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Hum Immunol 2005; 66(7):826-35.
27. Rybicki BA, Maliarik MJ, Poisson LM. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 2003; 167: 444-449.
28. Sato H, Grutters J, Pantelidis P. et al. HLA-DQB1*0201: a marker for good prognosis in british and dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27:406-11.
29. Grutters JC, Ruven HJT, Sato H, et al. MHC haplotype analysis in Dutch sarcoidosis patients presenting with Löfgren's syndrome. In: Grutters JC (Ed.). Genetic polymorphisms and phenotypes in sarcoidosis. Utrecht, Thesis University Utrech, 2003:85-96.
30. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumor necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65(2):163-71.
31. Berlin M, Fogdell-Hahn A, Olerup O, et al. HLA - DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-5.
32. Grutters JC, Sato H, Pantelidis P, et al. Analysis of IL-6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vas Diffuse Lung Dis 2003; 20(1):20-7.
33. Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clinics in Dermatology 2007; 25:242-9.
34. Somoskovi A, Zissel G, Seitzer U, et al. Polymorphisms at position - 308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999; 11 (11): 882-887.
35. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor - 857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119-1124.
36. Grutters JC, Ruven HJT, Sato H, et al. TNF promotor haplotypes associate with clinical phenotypes and prognosis in sarcoidosis. In: Grutters JC (Ed.). Genetic polymorphisms and phenotypes in sarcoidosis. Utrecht, Thesis University Utrecht; 2003: 49-66.
37. Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V, Welsh KI, Vacha J, du Bois RM, Petrek M. Association of tumor necrosis factor-α, lymphotoxin-α and DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65:163-717
38. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promotor gene polymorphism in sarcoidosis. Cytokine 1997; 9: 787-90.
39. Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19.
40. Labunski S, Posern G, Ludwig S, et al. Tumour necrosis factor -alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81(1):18-21.
41. Yamaguchi E, Itoh A, Hizawa N, et al. The gene polymorphism of tumour necrosis factor-beta, but not that of tumour necrosis factor-alpha, is associated with prognosis of sarcoidosis. Chest 2001; 119 (3): 753-61.
42. Takashigue N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54(2):191-3.